Cary Street Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.4M Buy
21,689
+269
+1% +$81.7K 0.21% 111
2026
Q1
$4.58M Sell
21,420
-2,094
-9% -$468K 0.11% 190
2025
Q4
$4.03M Sell
23,514
-850
-3% -$132K 0.1% 206
2025
Q3
$3.26M Sell
24,364
-166
-0.7% -$17.6K 0.08% 241
2025
Q2
$2.39M Buy
24,530
+613
+3% +$48.6K 0.07% 288
2025
Q1
$1.74M Sell
23,917
-645
-3% -$50.8K 0.06% 307
2024
Q4
$1.77M Buy
+24,562
New +$1.86M 0.06% 292

Other funds holding LRCX

Cary Street Partners's LRCX Position: Q2 2026 in Review

Cary Street Partners increased its Lam Research (LRCX) stake by 1.3% in Q2 2026, buying an estimated $81.7K and bringing the position to 21,689 shares worth $9.4M. The position accounts for 0.21% of the portfolio, ranked #111.

Cary Street Partners first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 973 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Cary Street Partners held 21,689 shares of Lam Research worth $9.4M as of Q2 2026.
  • Cary Street Partners bought 269 Lam Research shares in Q2 2026, an estimated $81.7K.
  • Lam Research made up 0.21% of Cary Street Partners's portfolio in Q2 2026, its #111 holding.
  • Cary Street Partners first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 973 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.